Invuity’s patented Intelligent Photonics™ devices provide direct visualization of the surgical cavity enabling enhanced precision, efficiency and safety. Our technology is integrated into sophisticated retractor systems, handheld devices and intracavity drop-in illuminators; each utilizing our proprietary waveguide technology that directs and shapes light into broad, uniform illumination to provide enhanced direct visualization inside dark surgical cavities. In addition, it converts traditional thermally hot, concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity.
Transforming Minimal access Surgeries Through Advanced Visualization
Invuity is committed to leveraging advanced photonics technology to transform and create a new standard of care for minimal access surgery.
SAN FRANCISCO, Nov. 28, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today announced that company management is scheduled to present at the upcoming 28th Annual Piper Jaffray Healthcare Conference at the Lotte New York Palace in New York on Wednesday, November 30th at 3:00 p.m. Eastern Time. A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the prese...Read More
SAN FRANCISCO, Nov. 09, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today announced that company management is scheduled to present at the following upcoming investor conferences: The Stifel Healthcare Conference on Tuesday, November 15, 2016 at 11:45 a.m. ET in New York City. The Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 17, 2016 at 3:30 p.m. ET in New York City A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available s...Read More
Updates 2016 revenue guidance and introduces 2017 revenue guidance Received FDA 510(k) clearance for PhotonBlade™ SAN FRANCISCO, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today reported financial results for the third quarter and nine-months ended September 30, 2016. Q3 2016 Highlights Revenue grew 52% to $8.5 million compared to revenue of $5.6 million in the 2015 third quarter. Gross margin expansion continued to 73.8% compared to 63.6% in the 2015 third quarter. Approximately 700 hospitals purchased Invuity devices in the third quarter of 2016, up from 465 hospitals in the third quarter of 2015. Approximately 212...Read More
“Invuity has effectively married two critical technologies and addressed a pressing clinical need of visualization. The Saber Yankauer is one of the most significant technological advancements in orthopaedic surgery this year.”
Head of Orthopaedic Oncology
UAB Medical Center, Birmingham, AL
“Invuity’s Intelligent Photonics Technology enables me to do what I do when performing nipple sparing mastectomies and oncoplastic breast conservation procedures. It makes all the difference.”
Principal Investigator and Chair of the Nipple Sparing Mastectomy Registry for the American Society of Breast Surgeons
“These retractors are a must for anyone looking to do nipple sparing mastectomies. I feel we can save significant amounts of surgical time since we can see better without the worry of burn injury or fire hazard often found with fiber optic light.”
New York, NY